Lukas Scheibler
Chief Tech/Sci/R&D Officer at APELLIS PHARMACEUTICALS, INC.
Net worth: 3 M $ as of 2024-04-29
Lukas Scheibler active positions
| Companies | Position | Start | End |
|---|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - | - |
| Corporate Officer/Principal | 2019-03-31 | - |
Career history of Lukas Scheibler
Former positions of Lukas Scheibler
| Companies | Position | Start | End |
|---|---|---|---|
| ACUCELA INC | Corporate Officer/Principal | 2015-08-16 | 2017-11-30 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | 2011-09-30 | 2015-06-30 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 2001-12-31 | 2008-05-31 |
Training of Lukas Scheibler
| University of Basel | Graduate Degree |
| University of Lausanne | Doctorate Degree |
Statistics
International
| United States | 5 |
| Switzerland | 3 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Lukas Scheibler
- Experience
